US 12054519
Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
granted A61KA61K39/155A61K9/0019
Quick answer
US patent 12054519 (Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K39/155, A61K9/0019, A61K9/0043, A61P